Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985; 312: 1465-1472. [No author listed]
Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-715.
Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery -The clue to pelvic recurrence? Br J Surg 1982; 69: 613-616.
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
Peeters KC, Marijnen CA, Nagtegaal ID, et al: The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006; 24: 4620.
Czito BG, Willett CG, Bendell JC. Combined-modality therapy for rectal cancer: Future prospects. Clin Colorectal Cancer 2007; 6: 625-633.
Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-844.
Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 2012; 30: 1770-1776.
Cercek A, Weiser MR, Goodman KA, et al. Complete pathologic response in the primary of rectal or colon cancer treated with FOLFOX without radiation. J Clin Oncol 2010; 28: 15s.
Berends FJ, Kazemier G, Bonjer HJ, et al. Subcutaneous metastases after laparoscopic colectomy. Lancet 1994; 344: 58.
Nelson H, Sargent DJ, Wieand HS, et al. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004; 350: 2050-2114.
Braga M, Vignali A, Gianotti L, et al. Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Ann Surg 2002; 236: 759-767.
Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomized controlled trial. Lancet 2005; 365: 1718-1726.
Lacy AM, García-Valdecasas JC, Delgado S, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomized trial. Lancet 2002; 359: 2224-2229.
Liang JT, Huang KC, Lai HS, et al. Oncologic results of laparoscopic versus conventional open surgery for stage II or III left-sided colon cancers: a randomized controlled trial. Annals of Surgical Oncology 2007; 14: 109-117.
Milsom JW, Böhm B, Hammerhofer KA, et al. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. Journal of the American College of Surgeons 1998; 187: 46-57.
Heikkinen T, Msika S, Desvignes G, et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomized trial. Lancet Oncology 2005; 6: 477-484.
Nandakumar G, Fleshman JW. Laparoscopy for rectal cancer. Surgical Oncology Clinics of North America 2010; 19: 793-802.
KL Leung, Kwok Y, Lam W, et al. Laparoscopic resection of rectosigmoid carcinoma: prospective randomized trial. Lancet 2004; 363: 1187-1192.
Leung KL, Lee JFY, et al. Long-term morbidity and oncologic outcomes of laparoscopic-assisted anterior resection for upper rectal cancer: ten-year results of a prospective, randomized trial. Diseases of the Colon and Rectum 2009; 52: 558-566.
Leung KL, Lee JFY, et al. Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial. Annals of Surgical Oncology; 15: 2418-2425.
Laurent C, Leblanc F, Wütrich P, et al. Laparoscopic versus open surgery for rectal cancer: longterm oncologic results. Ann Surg 2009; 250: 54-61.
Bretagnol F, Lelong B, Laurent C, et al. The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma. Surgical Endoscopy and Other Interventional Techniques 2005; 19: 892-896.
Araujo SE, et al. Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. Revista do Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo 2003; 58: 133-140.
Aziz O, Constantinides V. Tekkis PP, et al. Laparoscopic versus open surgery for rectal cancer: a meta-analysis. Annals of Surgical Oncology 2006; 13: 413-424.
Baek JH, McKenzie S, García-Aguilar J, Pigazzi A. Oncologic outcomes of robotic-assisted total mesorectal excision for the treatment of rectal cancer. Ann Surg 2010; 251: 882-886.
Baek JH, Pastor C, Pigazzi A. Robotic and laparoscopic total mesorectal excision for rectal cancer: a case matched study. Surgical Endoscopy and Other Interventional Techniques 2011; 25: 521-525.
Baik SH, Kwon HY, Kim JS, et al. Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study. Annals of Surgical Oncology 2009; 16: 1480-1487.
Bianchi PP, Ceriani V, Locatelli A, et al. Robotic versus laparoscopic total mesorectal excision for rectal cancer: a comparative analysis of oncological safety and short-term outcomes. Surgical Endoscopy and Other Interventional Techniques 2010; 24: 2888-2894.
JS Park, GS Choi, KH Lim. “Robotic-assisted versus laparoscopic surgery for low rectal cancer: case-matched analysis of short-term outcomes”, Ann Surg Oncol. 2010 Dec; 17(12): 3195-202.